We provide you with 20 years of free, institutional-grade data for AKBA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AKBA. Explore the full financial landscape of AKBA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Butler John P. | Open Market Purchase | 69,270 | $1.25 | 2026-03-05 | |
| Malabre Richard C | Sale | -49,524 | $1.39 | $68,838 | 2026-02-04 |
| Grund Nicholas | Sale | -84,829 | $1.39 | $117,912 | 2026-02-04 |
| Burke Steven Keith | Sale | -67,658 | $1.39 | $94,045 | 2026-02-04 |
| Rucci Carolyn M. | Sale | -69,772 | $1.39 | $96,983 | 2026-02-04 |
| Ostrowski Erik | Sale | -34,951 | $1.39 | $48,582 | 2026-02-04 |
| Butler John P. | Grant, award...etc | 175,250 | $1.41 | 2026-02-04 | |
| Butler John P. | Sale | -341,305 | $1.39 | $474,414 | 2026-02-04 |
| Grund Nicholas | Grant, award...etc | 204,000 | 2026-02-03 | ||
| Burke Steven Keith | Grant, award...etc | 204,000 | 2026-02-03 | ||
| Rucci Carolyn M. | Grant, award...etc | 190,000 | 2026-02-03 | ||
| Malabre Richard C | Grant, award...etc | 79,000 | 2026-02-03 | ||
| Ostrowski Erik | Grant, award...etc | 204,000 | 2026-02-03 | ||
| Butler John P. | Grant, award...etc | 743,000 | 2026-02-03 | ||
| Rucci Carolyn M. | Initial | 2026-02-03 | |||
| Ostrowski Erik | Sale | -41,314 | $3.67 | $151,622 | 2025-07-01 |
| Smith Cynthia | Grant, award...etc | 35,700 | 2025-06-11 | ||
| Wolf Myles | Grant, award...etc | 35,700 | 2025-06-11 | ||
| ROGERS MICHAEL W | Grant, award...etc | 35,700 | 2025-06-11 | ||
| GILMAN STEVEN C | Grant, award...etc | 35,700 | 2025-06-11 | ||
| Malabre Richard C | Sale | -15,000 | $4.01 | $60,150 | 2025-06-11 |
| Malabre Richard C | Derivatives Exercise | 15,000 | 2025-06-11 | ||
| FRIESON RON | Grant, award...etc | 35,700 | 2025-06-11 | ||
| ADAMS ADRIAN | Grant, award...etc | 35,700 | 2025-06-11 | ||
| ZUMWALT LEANNE M | Grant, award...etc | 35,700 | 2025-06-11 | ||
| Malabre Richard C | Sale | -13,334 | $3.53 | $47,069 | 2025-06-05 |
The information provided in this report about AKBA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Akebia Therapeutics, Inc(NASDAQ:AKBA) 